This is not a financial advice! Most info on the chart. Trade carefully!
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. It primarily focuses on the development of its lead product candidate DefenCath/Neutrolin, an anti-infective solution for the reduction and...
Been a bull I this medical device company since 2017. One of the most BULLISH setups I’ve found. Monthly chart has double bottomed on bullish divergence and we are completing an inverse head and shoulders pattern which is now at the neckline. Monthly RSI is about to break out which I can confirm by looking at the volume as well as the PPO, which is moving apart...
Neutrolin, a catheter drug that helps prevent infection, biofilm and thrombosis in ICU and blood dialysis patients, won QIDP designation from the FDA. The chart has responded positively.